Gefitinib

Category: Cancer

Gefitinib Overview

Gefitinib (ZD1839) (INN, /ftnb/, trade name Iressa)[1] is a drug used for certain breast, lung and other cancers. Gefitinib is an EGFR inhibitor, like erlotinib, which interrupts signaling through the epidermal growth factor receptor (EGFR) in target cells. Therefore, it is only effective in cancers with mutated and overactive EGFR. It is marketed by AstraZeneca and Teva. Contents 1 Mechanism of action 2 Clinical uses 3 Experimental uses 4 Studies 4.1 EGFR diagnostic tests...

Read more Gefitinib Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Gefitinib

Recent Gefitinib Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Other drugs which contain Gefitinib or a similar ingredient: (1 result)

• IRESSA Gefitinib1 discussion